Lidocaine Spray for Brain Freeze

DE
Overseen ByDana E Schulz, DO
Age: 18+
Sex: Any
Trial Phase: Phase 1
Sponsor: Wright State University

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether a nasal spray with lidocaine (a local anesthetic) can prevent brain freeze, the headache that occurs when eating something cold. Researchers aim to determine if this spray can either stop the pain or shorten its duration. Participants will receive either the lidocaine spray or a placebo (a fake treatment) for comparison. The trial seeks individuals who have experienced brain freeze and are medical students or residents at Wright State University. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants a chance to be among the first to receive this innovative treatment.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

Is there any evidence suggesting that this treatment is likely to be safe for humans?

Research shows that using lidocaine as a skin treatment is usually safe. Some studies have found it helpful for relieving headaches. However, excessive lidocaine in the body can cause serious side effects like dizziness or tingling sensations.

In other treatments, a stronger 10% lidocaine spray for the nose proved effective, suggesting that the 4% solution in this trial might also be safe and effective. The key to safety and effectiveness lies in using the correct amount and method. The researchers have safety measures in place to manage any unexpected reactions.

Participants should discuss any concerns with the trial team to fully understand the possible risks and benefits.12345

Why do researchers think this study treatment might be promising?

Unlike typical remedies for brain freeze, which usually involve waiting it out or using general warming techniques, this new lidocaine spray treatment acts directly on the nerves responsible for the pain. Researchers are excited because lidocaine is a topical anesthetic that temporarily numbs the area, offering quick relief. This treatment is administered through intranasal atomization, directly targeting the nerves in the head, which is a novel delivery method compared to traditional oral or external cooling methods. This precise and fast-acting approach could revolutionize how we handle the sudden, sharp headaches caused by eating or drinking something cold.

What evidence suggests that lidocaine spray might be an effective treatment for brain freeze?

Research has shown that lidocaine nasal spray can help relieve headaches, including migraines. One study found that a 10% lidocaine nasal spray eased headaches, though there was a reasonable chance of recurrence. Another study found that intravenous lidocaine effectively treated migraines in children and teenagers, with over 90% experiencing relief. Although strong evidence does not specifically support lidocaine's effect on brain freeze, its success with similar headaches suggests potential efficacy. This trial will test a 4% lidocaine nasal spray to determine if it can reduce brain freeze symptoms by blocking a nerve bundle linked to headache pain.12367

Who Is on the Research Team?

BP

Brian P Murray, DO

Principal Investigator

Wright State University

Are You a Good Fit for This Trial?

This trial is for Wright State University Emergency Medicine residents and medical students over 18 who've had at least one brain freeze. It's not specified who can't join, but typically those with allergies or conditions affected by the treatments would be excluded.

Inclusion Criteria

I am an EM resident or medical student at Wright State.
I have experienced a brain freeze before.
I am over 18 years old.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-medicated Phase

Participants rapidly drink up to ½ of a 32 fluid oz ice-cold slushy to induce a brain freeze. The time to onset, intensity, location, and duration of the headache are recorded.

1 day
1 visit (in-person)

Treatment Phase

Participants receive either 1 mL of 4% lidocaine or 0.9% normal saline administered by intranasal atomization. They then rapidly drink up to ½ of a 32 fluid oz ice-cold slushy to induce a brain freeze. The time to onset, intensity, location, and duration of the headache are recorded.

1 day
1 visit (in-person)

Follow-up

Participants are monitored for any side effects and the degree of decreased pain/duration of brain freeze after the sphenopalatine ganglion block.

5 months

What Are the Treatments Tested in This Trial?

Interventions

  • Lidocaine Topical 4% Topical Solution
Trial Overview The study tests if a sphenopalatine ganglion block using intranasal atomized lidocaine can prevent or reduce pain/duration of brain freezes compared to Bitrex and saline solutions.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention ArmExperimental Treatment1 Intervention
Group II: Placebo ArmPlacebo Group2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Wright State University

Lead Sponsor

Trials
47
Recruited
55,300+

Published Research Related to This Trial

In a study of 26 children and adolescents with status migraine, intravenous (IV) lidocaine was found to be a safe and effective treatment, with 90.3% of patients experiencing pain resolution.
On average, patients saw a significant reduction in pain scores within 16.3 hours, and the treatment was well-tolerated, with only one patient experiencing side effects that required interruption of the infusion.
Safety and Efficacy of IV Lidocaine in the Treatment of Children and Adolescents With Status Migraine.Ayulo, MA., Phillips, KE., Tripathi, S.[2019]
A case study of a 5-month-old infant revealed that seizures can occur due to toxicity from oral viscous lidocaine, highlighting a serious risk associated with its use in young children.
Despite previous reports of lidocaine toxicity, many healthcare providers remain unaware of its potential adverse effects, emphasizing the need for increased awareness and caution when prescribing topical lidocaine for pediatric patients.
Toxicity--seizures in an infant caused by (or related to) oral viscous lidocaine use.Smith, M., Wolfram, W., Rose, R.[2019]

Citations

Evaluation of efficacy of intra-nasal lidocaine for headache ...According to these two studies we conclude 10% intranasal lidocaine spray is effective in headache relief with acceptable rate of relapse. Chae et al., (2006) ...
Lidocaine Spray for Brain Freeze · Info for ParticipantsIn a study of 26 children and adolescents with status migraine, intravenous (IV) lidocaine was found to be a safe and effective treatment, with 90.3% of ...
Sphenopalatine Ganglion Block Without CatheterAnecdotal reports of nasal lidocaine sprays, which are unlikely to achieve an SPG block, eliminating headache support the concept of a more ...
Intranasal lidocaine for acute migraine: A meta-analysis of ...Intranasal lidocaine has been shown to be effective in treating patients with acute migraines; however, its efficacy is still controversial.
Sphenopalatine ganglion: block, radiofrequency ablation and ...The strongest evidence lies in treating with 8% lidocaine nasal spray in the affected nostril. The analgesia is effective but temporary (4.3 h).
MSDS - 4 % Lidocaine HCl Topical SolutionMinimum Personal Protective. Equipment should be rubber gloves, rubber boots, face shield, and Tyvek suit. Access to the spill areas should be restricted.
4% Xylocaine -MPF (lidocaine HCl) Sterile SolutionThe safety and effectiveness of lidocaine depend on proper dosage, correct technique, adequate precautions, and readiness for emergencies. Resuscitative ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security